Hefei Zhaofeng Keda Pharmaceutical

Hefei Zhaofeng Keda Pharmaceutical is a Chinese pharmaceutical manufacturing company and a subsidiary of Grand Pharmaceutical (China) Co., Ltd. Established in 1994 and based in Hefei, Anhui Province, the company specializes in the development and production of chemical drugs and traditional Chinese medicine preparations. Its core therapeutic focus includes hepatology, dermatology, and respiratory medicine, with its flagship product, Compound Glycyrrhizin Tablets, being widely used for chronic liver disease and inflammatory skin conditions. The company operates multiple GMP-certified production lines for oral dosage forms such as tablets, capsules, and granules, serving as a key manufacturing hub within the Grand Pharma group's domestic supply chain.